查詢結果分析
來源資料
相關文獻
- 肺癌胗斷與治療
- 小細胞肺癌復發部位之型態分析
- Radiation Recall Dermatitis Induced by Gemcitabine--A Case Report
- Combination Versus Alternating Chemotherapy in Small-Cell Lung Cancer
- Long-Term Survival after Induction Therapy Followed by Concurrent Target-Radiotherapy of an Unresectable Stage IIIB Non-Small Cell Lung Cancer Patient: Case Report
- Treatment Results of Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer
- Ifosfamide-Based Chemotherapy for Previously Treated Lung Cancer Patients
- Malignant Primary Extragonadal Germ Cell Tumors of Mediastinum--An Analysis of Clinical and Radiological Features in 15 Cases
- 非小細胞肺癌術前輔助性化學治療的經驗
- Radiation Therapy in Primary Central Nervous System Lymphoma
頁籤選單縮合
| 題 名 | 肺癌胗斷與治療=Lung Cancer Diagnosis and Treatment |
|---|---|
| 作 者 | 劉會平; | 書刊名 | 腫瘤護理雜誌 |
| 卷 期 | 4:2 民93.12 |
| 頁 次 | 頁25-34 |
| 分類號 | 416.224 |
| 關鍵詞 | 肺癌; 外科手術; 放射治療; 化學治療; Lung cancer; Surgery; Chemoradiotherapy; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 近年來世界各國肺癌的發病率持續上升,不管男性或女性患者皆有顯著增加。雖然過去十年各種冶療的進步如化療或化療結合放療,其存活率普遍並不盡理想。各分期總體五年存活率不到15%。目前醫學文獻顯示第一期非小細胞肺癌病人的手術預後最好,其五年存活率約在50-75%之間,第二期則為30-50%,第三期則僅剩5-25%。通常肺癌病人手術後復發多發生在手術後的前一,二年之內最容易見到。一般臨床上遠處轉移的機會又比局部復發的可能性較高。 |
| 英文摘要 | The incidence of lung cancer has increased rapidly; lung cancer is the most common cause of cancer deaths in both men and women worldwide. Despite advances in treatment, such as combination chemotherapy and chemoradiation, survival rate has improved very little over the past few decades. The 5-year survival rate for all stages is less than 15%. As revealed in the recent published literature, stage I lung cancer has the best result after surgery, with five year survival rate around 50-75%, followed by 30-50% in stage Ⅱ and 5-25% left in stage Ⅲ lung cancer. The most common recurrent period was within 2 years after surgical resection. Clinically, distant metastasis happens more frequently than the local recurrence. |
本系統中英文摘要資訊取自各篇刊載內容。